Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaele De Palma

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
The Journal of Allergy and Clinical Immunology|January 9, 2023
Patients with CVID have their own "gut feeling" for virusesRaffaele De Palma
The New England Journal of Medicine|October 15, 2011
Antagonistic T-cell subsets in skin diseasesFrancesco Borriello, Raffaele De Palma
Frontiers in Immunology|April 8, 2021
Editorial: Etiopathogenesis of Systemic Sclerosis: An UpdateGiuseppina Stifano, Raffaele De Palma
The New England Journal of Medicine|June 14, 2008
Rituximab in relapsing-remitting multiple sclerosisRaffaele De Palma, Adelina Sementa
European Journal of Immunology|December 7, 2017
A simple twist of phosphate: Immunological synapse formation and T cell receptor signaling outcome in regulatory T cellsTalal A Chatila, Raffaele De Palma
The International Journal of Biochemistry & Cell Biology|March 15, 2018
HDAC inhibitors as epigenetic regulators for cancer immunotherapyMariarosaria Conte, Raffaele De Palma, Lucia Altucci
Cancers|August 19, 2020
Anti-cancer Immunotherapies Targeting TelomeraseSimone Negrini, Raffaele De Palma, Gilberto Filaci
Oncoimmunology|December 25, 2012
Senescence and NFκB: A trojan horse in tumors?Elvira Crescenzi, Raffaele De Palma, Antonio Leonardi
International Journal of Molecular Sciences|October 9, 2019
Prognostic Factors and Biomarkers of Responses to Immune Checkpoint Inhibitors in Lung CancerAndrea Bianco, Fabio Perrotta, Giusi Barra, et al.
Rheumatology (Oxford, England)|April 27, 2010
Peripheral T cells from patients with early systemic sclerosis kill autologous fibroblasts in co-culture: is T-cell response aimed to play a protective role?Raffaele De Palma, Elena D'Aiuto, Serena Vettori, et al.
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
The Journal of Allergy and Clinical Immunology|January 9, 2023
Patients with CVID have their own "gut feeling" for virusesRaffaele De Palma
The New England Journal of Medicine|October 15, 2011
Antagonistic T-cell subsets in skin diseasesFrancesco Borriello, Raffaele De Palma
Frontiers in Immunology|April 8, 2021
Editorial: Etiopathogenesis of Systemic Sclerosis: An UpdateGiuseppina Stifano, Raffaele De Palma
The New England Journal of Medicine|June 14, 2008
Rituximab in relapsing-remitting multiple sclerosisRaffaele De Palma, Adelina Sementa
European Journal of Immunology|December 7, 2017
A simple twist of phosphate: Immunological synapse formation and T cell receptor signaling outcome in regulatory T cellsTalal A Chatila, Raffaele De Palma
The International Journal of Biochemistry & Cell Biology|March 15, 2018
HDAC inhibitors as epigenetic regulators for cancer immunotherapyMariarosaria Conte, Raffaele De Palma, Lucia Altucci
Cancers|August 19, 2020
Anti-cancer Immunotherapies Targeting TelomeraseSimone Negrini, Raffaele De Palma, Gilberto Filaci
Oncoimmunology|December 25, 2012
Senescence and NFκB: A trojan horse in tumors?Elvira Crescenzi, Raffaele De Palma, Antonio Leonardi
International Journal of Molecular Sciences|October 9, 2019
Prognostic Factors and Biomarkers of Responses to Immune Checkpoint Inhibitors in Lung CancerAndrea Bianco, Fabio Perrotta, Giusi Barra, et al.
Rheumatology (Oxford, England)|April 27, 2010
Peripheral T cells from patients with early systemic sclerosis kill autologous fibroblasts in co-culture: is T-cell response aimed to play a protective role?Raffaele De Palma, Elena D'Aiuto, Serena Vettori, et al.
Pageof 11